$28.58 +0.34 (1.20%) AstraZeneca Shs Sponsored American Deposit Share Repr 1/2 Sh - New York Stock Exchange, Inc.

Jan. 13, 2017 | 04:00 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 28.58
Trade Time: Jan 13 04:00 PM Eastern Daylight Time
Change: +0.34 (1.20%)
Prev Close: 28.24
Open: 28.36
Bid: 28.54
Ask: 28.61
  1. Analysts See Merck Rally Continuing After Lung Cancer Drug News

    TalkMarkets | Jan. 12, 2017 | 14:31PM EST
  2. Bristol-Myers Threatens Merck's 'Head Start' In Lung Cancer: Analyst

    Investors Business Daily | Jan. 12, 2017 | 11:14AM EST
  3. Merck Lung-Cancer Drug May Get OK For Large Patient Population

    Investors Business Daily | Jan. 11, 2017 | 12:28PM EST
  4. Bristol-Myers slips after FDA gives Merck lung cancer therapy priority review

    TalkMarkets | Jan. 11, 2017 | 11:50AM EST
  5. Which Top 5 Biotech Stocks In 2016 Are Slated For Triple-Digit Gains?

    Investors Business Daily | Dec. 30, 2016 | 12:45PM EST
  6. Which Top 5 Biotech Stocks In 2016 Are Slated For Triple-Digit Gains?

    Investors Business Daily | Dec. 30, 2016 | 12:45PM EST
  7. Cempra Plunges To 52-Week Low, Shire Drug Label Expanded

    TalkMarkets | Dec. 30, 2016 | 10:33AM EST
  8. Stock Futures Lull, Pfizer Climbs On AstraZeneca Deal

    Investors Business Daily | Dec. 23, 2016 | 08:03AM EST
  9. Tesaro Ovarian Cancer Drug Gets Priority Review After FDA OKs Clovis Med

    Investors Business Daily | Dec. 20, 2016 | 11:28AM EST
  10. Conatus Pharma Skyrockets On Novartis NASH Liver Drug Licensing Deal

    Investors Business Daily | Dec. 19, 2016 | 17:52PM EST
  11. Clovis Jumps After Securing FDA Approval For Ovarian Cancer Drug

    TalkMarkets | Dec. 19, 2016 | 17:18PM EST
  12. Bristol-Myers Will Gain In Lung Cancer Square-Off Vs. Merck: Jefferies

    Investors Business Daily | Dec. 19, 2016 | 14:25PM EST
  13. Clovis Stock Rallies After AstraZeneca-Rivaling Ovarian Cancer Win

    Investors Business Daily | Dec. 19, 2016 | 13:28PM EST
  14. Jefferies Says Sell Merck, Buy Bristol-Myers Heading Into New Year

    TalkMarkets | Dec. 19, 2016 | 12:48PM EST
  15. Missing Phrase May Give Clue To Alexion Shake-Up, Analyst Says

    Investors Business Daily | Dec. 13, 2016 | 15:13PM EST
Trading Center